DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
JN
Jupiter NeurosciencesClinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.
1 Pulse story
Total Raised
$138M
Drug FarmJupiter Neurosciences
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
—
Shanghai, China / New York, NY
HQ
Jupiter, Florida
Private
Status
Public (JUNS)
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Jupiter Neurosciences investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Drug Farm and Jupiter Neurosciences.